Here are the latest venture capital, seed, and angel deals for NYC startups for 7/30/18. This page will be updated throughout the day to reflect any new fundings.
Simon Data — $20M – Series B
Simona Data, the end-to-end customer data platform for marketing, has raised $20M in Series B funding from investors that include Polaris Ventures, .406 Ventures, F-Prime Ventures, and Commerce Ventures. Founded by Jason Davis, Joshua Neckes, and Matt Walker in 2013, Simon Data has now raised a total of $32M in funding over five funding rounds.
Full coverage of Simon’s Series B funding.
Willow — $2.5M – Seed
Willow, the direct-to-consumer brand offering incontinence underwear, has raised $2.5M in seed funding from investors that include Founders Fund, Wildcat Capital Management, Two River, Oscar Salazar, Brian Levy, and FirstMark Capital. Willow was founded by William Herlands earlier in this year.
Fora — $1.4M – Seed
Brooklyn-based Fora, the makers of dairy-free food using aquafaba, has raised $1.4M in Seed funding led by New Crop Capital. This is the first reported round of funding for Fora, which was founded by Aidan Altman and Andrew McClure in 2017.
Troops — $7.7M
Troops, the Salesforce automation platform integrated with Slack, has raised an additional $7.6M in funding according to a recent SEC filing. Founded by Dan Reich, Greg Ratner, and Scott Britton in 2015, Troops has now raised a total of $17.3M in funding over three funding rounds.
Investors in previous rounds include First Round Capital, Felicis Ventures, Great Oaks Venture Capital, Founder Collective, NextView Ventures, Chicago Ventures, Susa Ventures, E-Merge, Aspect Ventures, Joshua Schachter, Flight Ventures, Flight Ventures, Vast Ventures, Jason Finger, Slack, Gokul Rajaram, Nat Turner, Zach Weinberg, Pierre Valade, Pierre Valade, Wiley Cerilli, David Yaffe, Brian Distelburger, Andrew Levy, Jaspar Weir, Ken Landis, Jack Groetzinger, Bryce Maddock, Kenny Herman, and Andy Monfried.
Phosphorus — $10.5M
Phosphorus, the clinical data network to better understand and harness the human genome, has raised an additional $10.5M in funding according to a recent SEC filing using a combination of debt and equity. The company had previously raised $10M in funding in 2016 led by Firstmark Capital.
